Results 41 to 50 of about 3,098 (190)

Aortic involvement in relapsing polychondritis: case-based review [PDF]

open access: yes, 2021
Relapsing polychondritis is a systemic inflammatory disease that mainly affects ears, nose, eyes, joints, and large airway. Relapsing polychondritis may also affect cardiac valves and large vessels with the aorta being most frequently involved.
Erdogan, Mustafa   +3 more
core   +1 more source

Prevalence and comorbidity of relapsing polychondritis [PDF]

open access: yes, 2016
Jonas F Ludvigsson,1–4 Ronald van Vollenhoven5 1Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, 2Department of Pediatrics, Örebro University Hospital, Örebro, Sweden; 3Division of Epidemiology and ...
van Vollenhoven, RF   +5 more
core   +1 more source

Relapsing polychondritis: prevalence of cardiovascular diseases and its risk factors, and general disease features according to gender

open access: yesRevista Brasileira de Reumatologia
The comorbidities in relapsing polychondritis have been scarcely described in the literature. Moreover, apart from a few relapsing polychondritis epidemiological studies, no studies specifically addressing relapsing polychondritis distribution according ...
Pablo Arturo Olivo Pallo   +3 more
doaj   +1 more source

Relapsing Polychondritis

open access: yesPhilippine Journal of Otolaryngology Head and Neck Surgery, 2009
Relapsing Polychondritis is an autoimmune disease that can present with a variety of non-specific symptoms involving the ears, nose, throat, head and neck.
Charina Melinda C. Elgar-Reyes   +1 more
doaj   +3 more sources

Respiratory subtype of relapsing polychondritis frequently presents as difficult asthma: a descriptive study of respiratory involvement in relapsing polychondritis with 13 patients from a single UK centre

open access: yesERJ Open Research, 2021
Introduction Relapsing polychondritis is a rare multisystem vasculitis characterised by recurrent cartilage inflammation. Respiratory involvement, of which tracheobronchomalacia (TBM) is the commonest form, is difficult to treat and is linked to ...
Shirish Dubey   +9 more
doaj   +1 more source

Relapsing Polychondritis [PDF]

open access: yesSeminars in Respiratory and Critical Care Medicine, 2002
Relapsing polychondritis (RP) is a rare disease causing inflammation and destruction of cartilage and other connective tissues. Specific laboratory aberrations are lacking. Predominant clinical manifestations include auricular chondritis, polyarthritis, nasal chondritis, ocular inflammation, audiovestibular damage, and respiratory tract chondritis.
Bruce A, Staats   +2 more
openaire   +4 more sources

RELAPSING POLYCHONDRITIS AND STROKE [PDF]

open access: yes
Relapsing polychondritis is a multisystemic autoimmune disease with a predilection for cartilaginous structures, causing recurrent episodes of chondritis.
Yıldız, Bülent   +5 more
core   +1 more source

An Interesting Case of Relapsing Polychondritis in A Young Girl [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2013
Relapsing polychondritis is an acute, recurrent and progressive inflammation and degeneration of cartilage and connective tissue including that within the tracheobronchial tree affecting men and women equally and usually in the middle age.
Shibani V Anchan   +4 more
doaj   +1 more source

Bronchial Mucosal Abnormalities in Idiopathic Subglottic Stenosis

open access: yesThe Laryngoscope, Volume 136, Issue 8, Page 3527-3533, August 2026.
Idiopathic subglottic stenosis (iSGS) is a challenging variant of airway stenosis associated with consistent distal airway abnormalities on bronchoscopy, including pits, depressions, and striations. Despite these findings, most patients demonstrate normal or mild–moderate obstruction on spirometry.
Sydney Ring   +4 more
wiley   +1 more source

Risk of urinary tract infection with SGLT2 inhibitor initiation in patients with immune‐mediated inflammatory diseases and type 2 diabetes: A target trial emulation using a Japanese hospital‐based claims database

open access: yesJournal of Diabetes Investigation, Volume 17, Issue 8, Page 1310-1321, August 2026.
In this target trial emulation of patients with immune‐mediated inflammatory diseases and type 2 diabetes, SGLT2 inhibitor initiation was not associated with a clear increase in UTI risk versus metformin, including across immunosuppressive therapy strata.
Hiroshi Tsushima   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy